Mrp Capital Investments, LLC Crinetics Pharmaceuticals, Inc. Transaction History
Mrp Capital Investments, LLC
- $110 Billion
- Q4 2024
A detailed history of Mrp Capital Investments, LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Mrp Capital Investments, LLC holds 35 shares of CRNX stock, worth $1,222. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35Holding current value
$1,222% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRNX
# of Institutions
251Shares Held
83.3MCall Options Held
23.3KPut Options Held
44.3K-
Vanguard Group Inc Valley Forge, PA9.09MShares$317 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.95MShares$243 Million0.07% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$218 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL5.89MShares$206 Million2.95% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.94MShares$173 Million0.03% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $1.88B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...